Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-09
Biography and Research Information
OverviewAI-generated summary
Sydnye Shuttlewoth's research focuses on characterizing mechanisms that can improve cancer immunotherapies. Her work investigates strategies to enhance CAR-T cell function and overcome resistance to combination therapies. Specifically, she has studied the activation of ATF6 as a means to improve efficacy in immune checkpoint blockade (ICB). Additionally, her research explores the generation of EZH2-inhibitor resistant CAR-T cells to sustain their function in combination treatment regimens.
Metrics
- Publications: 2
Selected Publications
-
Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy (2026)
-
Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy (2026)
Collaboration Network
Top Collaborators
Katherine Bronson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Daniel Fil
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Megan R. Reed
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Billie Heflin
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Brian Koss
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Alan J. Tackett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Sanjay Adhikary
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Jacob L Edmondson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Duah Alkam
Winthrop Rockefeller Foundation
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Katherine Wallis
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Nathan L. Avaritt
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Sean D. Taverna
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Similar Researchers
Based on overlapping research topics
Katherine Cruse
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Duah Alkam
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Mamatha Gaddam
University of Arkansas for Medical Sciences
CAR-T cell therapy research
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Alicia L. Graham
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Shelby N. Bess
University of Arkansas at Fayetteville
Cancer Immunotherapy and Biomarkers
Cancer Treatment and Pharmacology
Immune Response and Inflammation
L. Burdine
University of Arkansas at Little Rock
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications